Potential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs disease (Q27012822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2 references

26 January 2021

8 October 2022

Potential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

5 references

25 April 2019

31 July 2019

2 October 2019

15 December 2019

cell surface receptor

1 reference

31 July 2019

1 reference

2 October 2019

1 reference

15 December 2019

neuroprotective agent

1 reference

26 January 2021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Patrick Flood

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Kathleen P Ismond

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

1 reference

19 January 2014

7 references

25 April 2019

31 July 2019

2 October 2019

15 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

26 January 2021

8 October 2022

Journal of Immunology Research

8 references

25 April 2019

31 July 2019

2 October 2019

15 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

26 January 2021

8 October 2022

2014

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

103780

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

14 March 2020

6 references

25 April 2019

31 July 2019

2 October 2019

15 December 2019

26 January 2021

on focus list of Wikimedia project

8 October 2022

copyrighted

0 references

ScienceSource

0 references

cites work

β-arrestin Kurtz inhibits MAPK and Toll signalling in Drosophila development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Parkinson's disease: mechanisms and models

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Targeting of TAK1 in inflammatory disorders and cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Milestones in Parkinson's disease therapeutics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

beta2 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent/protein kinase A-independent pathway

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

beta-arrestin-biased agonism at the beta2-adrenergic receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Beta2-adrenoceptors: mechanisms of action of beta2-agonists

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Existence of functional beta1- and beta2-adrenergic receptors on microglia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Microglial cells and Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Rate of cell death in parkinsonism indicates active neuropathological process

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Norepinephrine protects cortical neurons against microglial-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

β2 adrenergic-mediated reduction of blood glutamate levels and improved neurological outcome after traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through β2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Beta2-adrenoreceptor agonist-enhanced recovery of locomotor function after spinal cord injury is glutathione dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3987873

Stereoselectivity at the β 2 -adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of β 2 -agonists

28 November 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F103780

Beta-adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo

21 January 2018

1 reference

12 December 2020

The beta-adrenoceptor

1 reference

12 December 2020

Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors

1 reference

12 December 2020

Targeting beta2-adrenoceptors for neuroprotection after cerebral ischemia: is inhibition or stimulation best?

1 reference

12 December 2020

Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human

1 reference

12 December 2020

Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF

1 reference

12 December 2020

Identifiers

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24741572%20AND%20SRC:MED&resulttype=core&format=json